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Abstract
Background: For patients hospitalised due to community-acquired pneumonia (CAP), mortality risk is usually
estimated with prognostic scores such as CRB-65 or CURB-65. For elderly patients, a new score referred to as CURSI
has been proposed which uses shock index (SI) instead of the blood pressure (B) and age (65) criteria. The new
score has not been externally validated to date.
Methods: We used data from a hospital-based CAP registry to compare the ability of CURSI, CURB-65 and
CRB-65 to predict mortality at day 30 after hospital admission. Patients were stratified by score points as well as
score-point-based risk categories, and mortality for each group was assessed. To compare test performance,
receiver-operating characteristic (ROC) curves were constructed, and the areas under the curve (AUROC) were
calculated with 95% confidence intervals (CI).
Results: We analysed 553 inpatients (45% females, median age 78 years) hospitalised between 2005 and 2009 for
CAP. Overall, mortality at day 30 was 11% (59/553). The study sample was characterised by advanced comorbidity
(chronic heart failure: 22%, chronic kidney failure: 27%) and functional impairment (nursing home residency: 26%,
dementia: 31%). All risk scores were significantly associated with 30-day mortality. The AUROC values with 95% CI
using score points for risk prediction were as follows: 0.63 [0.56-0.71] for CRB-65, 0.68 [0.61-0.75] for CURB-65
and 0.68 [0.61-0.75] for CURSI. The CURSI-defined low-risk group (0 or 1 score point) had a higher mortality (8%)
than the low-risk groups defined by CURB-65 and CRB-65 (4% and 3%, respectively). Lowering the cut-off for the
CURSI-defined low-risk group (0 point only) would lower the mortality to 4%, making it comparable to the
CURB-65-defined low-risk group.
Conclusions: In our study, the CURSI-defined low-risk group had a higher 30-day mortality than the low-risk groups
defined by CURB-65 and CRB-65. Lowering the cut-off value for the CURSI low-risk group would result in a mortality
comparable to the CURB-65-defined low risk group. Even then, however, CURSI does not perform better than the
established risk scores.
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Background
Community-acquired pneumonia (CAP) is a common
and potentially life-threatening infectious disease. In
Germany, the annual incidence of CAP is estimated at
400,000 to 680,000 infections per year [1]. In 2008, more
than 200,000 CAP patients in Germany were treated in a
hospital. Two-thirds were older than 70 years. In-hospital
mortality was about 13% [2]. Apart from the threat to in-
dividuals, the high incidence of CAP also poses a consid-
erable economic burden on the health care system: in
2008, the costs of pneumonia in Germany were estimated
to reach a total of $1.5 billion [3]. Around $900 million
was spent for inpatient treatment, which represents the
major part (>90%) of the direct costs [3,4].
For this reason, it is highly important to identify every
CAP patient‘s individual risk and severity of illness. To
predict short-term mortality in CAP patients, national
guidelines recommend the CURB-65 score [5,6]. In this
simple score, one score point is awarded for each pre-
sent risk factor (confusion, urea >7 mmol/L, respiratory
rate ≥30/min, low systolic (<90 mm Hg) or diastolic
(≤60 mm Hg) blood pressure, age ≥65 years). Increasing
score points indicate increasing mortality [7]. CRB-65, a
modification of CURB-65, is even easier to apply, since
the measurement of blood urea is omitted. Thus, it con-
sists of clinical parameters only that can be easily evalu-
ated by clinical assessment, making it a useful tool in the
ambulatory setting [7-10]. In line with the estimated risk
of mortality, both CURB-65 and CRB-65 divide patients
into three risk categories (‘low risk’, ‘intermediate risk’
and ‘high risk’) [7]. In recent years, both scores have been
extensively validated [9,11-15].
Myint et al. [16] proposed a variant of CURB-65, re-
ferred to as CURSI, in which the age criterion is omitted
and blood pressure is replaced by shock index, the ratio of
heart rate to systolic blood pressure. One point is awarded
when shock index values are higher than 1.0. Chrono-
logical age does not necessarily correlate with biological
ageing, which may weaken the age criterion. The generally
high prevalence of systolic hypertension in elderly patients
may invalidate the blood pressure criterion [16]. As the
shock index has been shown to be a predictor of mortality
in CAP patients [17], it may prove to be a better marker
for disease severity. In contrast to CRB-65 and CURB-65,
CURSI divides patients into only two categories. The pro-
posed risk score has not been externally validated to date.
Therefore, the aim of our study was to compare the per-
formance of the above-mentioned scores.
Methods
Setting and study population
This is a retrospective cohort study using data of the
Marienhospital in Herne, Germany, a tertiary care uni-
versity hospital with approximately 575 beds. It serves
approximately 21,000 inpatients and 50,000 outpatients
each year and provides unrestricted health care to the
population.
Since 2005, all German hospitals providing acute me-
dical care collect data on inpatients with CAP ≥18 years.
This has been made compulsory for the purpose of exter-
nal quality assurance. Variables included are: confusion
due to pneumonia, respiratory rate and blood pressure
upon admission to hospital, age, nursing home residency,
immobility, mechanical ventilation and whether or not
treatment was discontinued or not performed for various
reasons.
For this study, data on all adult CAP inpatients treated
at the Marienhospital Herne between 2005 and 2009
were extracted from the hospital’s CAP database. When
reviewing the medical records, the diagnosis of CAP was
considered to be confirmed if a patient presented at least
one clinical symptom consistent with pneumonia (cough,
dyspnoea, new or purulent sputum or fever) in combi-
nation with either a new pulmonary infiltrate or elevated
laboratory values of inflammation within 48 hours of hos-
pital admission in the absence of an alternative focus of
infection. In this context, we also ascertained that the in-
cluded patients did not suffer from acute exacerbation of
chronic obstructive pulmonary disease, pneumonia due to
other causes (for example aspiration, pulmonary embol-
ism or bronchial stenosis) or immunodeficiency (e.g., due
to HIV infection or chemotherapy). Laboratory values,
specifically urea, were gathered from the central labora-
tory server, and additional diagnoses were obtained from
the hospital information system. The patients’ pulse rate
was assessed by means of either the admitting physician’s
documentation or the electrocardiogram obtained at the
time of admission. Information about the patients’ vital
status and/or date of death was obtained from the respon-
sible local register office (City of Herne Office of Statistics
and Elections).
Patients who had discontinued or had not undergone
treatment, those on mechanical ventilation upon admis-
sion or whose pulse rate values were missing, as well as
patients referred from other hospitals were excluded.
Sample size and statistical analysis
To calculate the sample size, we used a dichotomous
risk factor (‘low risk’ versus ‘intermediate/high risk’) as
defined for example by the CURB-65 score. Data of all
adult inpatients that were treated at the hospital between
2001 and 2005 were available for sample size calculation.
The data of patients aged ≥ 65 years of age have been re-
ported elsewhere [18]. The data of adults aged < 65 years
are unpublished. Using data of all adults, short-term
mortality was strongly dependent on pneumonia seve-
rity, as assessed by CURB-65 [18]. On the basis of the
dataset, we could expect a 30-day mortality of 5% in the
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low risk and at least 12% in the intermediate-/high-risk
group. Using a significance level of 5% and a power of
80%, we calculated 248 cases per group with the chi-
square test, or at least 500 patients in total.
Categorical variables are presented in absolute num-
bers and proportions, and continuous variables are pre-
sented with median, mean and range. All patients were
stratified by score points as well as risk categories
using the different severity scores CRB-65, CURB-65
and CURSI. The corresponding 30-day mortality was
determined for each group. The association between
categorical variables was assessed using chi-square test.
We also calculated Odds Ratios (OR) with their corre-
sponding 95% confidence interval (95% CI). To demon-
strate the performance of the different scores in predicting
death at day 30 after admission, receiver operating charac-
teristic (ROC) curves were constructed for both score
points and risk categories, respectively. The associated
area under the ROC curve (AUROC) and corresponding
95% CI were calculated. For the identification of low-risk
groups as defined by the different risk scores, we also cal-
culated sensitivity, specificity and positive and negative
likelihood ratios, all with 95% CI.
To calculate the sample size as well as sensitivity, speci-
ficity, likelihood ratios and the corresponding 95% CI, we
used StatsDirect Software (version 2.7.9, 2012, StatsDirect
Ltd., UK). All other analyses were performed with SPSS
for Windows (version 21, 2012, IBM Inc., USA).
This study was approved by the ethics committee of
the University of Bochum, Germany (registration no.
4376–12).
Results
In total, 587 patients with CAP were identified by means
of the CAP database. Patients who either discontinued
or did not undergo treatment (18 patients), those on
mechanical ventilation upon admission (six patients), pa-
tients referred from other hospitals (four patients) or
whose pulse rate values were missing (six patients) were
excluded, leaving 553 patients for analysis. The baseline
characteristics are presented in Table 1.
The patients’ median age was 78.2 years (mean 74.2;
range 18.1–104.2). 78% were 65 or older. 246 patients
(45%) were female. The collected data indicate a high
prevalence of comorbidities, with over one-fifth of the
patients suffering from chronic heart failure or kidney dis-
ease. Furthermore, a high proportion of patients (>25%)
was immobile or living in nursing homes.
Among the 553 patients, 59 (10.7%) died within 30
days of admission. Age was strongly associated to mor-
tality. Mortality at day 30 was 5% (6/123) in patients
aged below 65 years, but 12% (53 / 430) in patients ≥ 65
years (p < 0.05; OR 2.74 [95% CI 1.15 – 6.54]). A compar-
able association was observed for shock index. In patients
with a shock index below 1.0, mortality was 9% (44/483),
whereas patients with a shock index ≥ 1.0 had a mortality
of 21% (15/70; p < 0.01; OR 2.72 [95% CI 1.42 – 5.21]).
Table 2 shows 30-day mortality according to the pneu-
monia severity scores CRB-65, CURB-65 and CURSI, or-
dered by score points and risk categories, respectively.
Overall, mortality increased significantly with increasing
score points and risk categories of each severity score.
The number of patients in the low-risk groups was low-
est for CRB-65 (87 patients) compared to both urea-based
severity scores (CURB-65: 211 patients; CURSI: 435 pa-
tients). Thirty-day mortality in the low-risk groups was
highest for the CURSI (34 patients, 8%). This high mortal-
ity could be reduced at the expense of group size by using
an alternative cut-off, i.e., defining only patients scoring 0
points as low-risk patients (instead of 0 or 1 point). In this
case, 195 patients would remain in the CURSI-defined
low-risk group. The resulting mortality in this group (8
patients, 4%) would be comparable to that of the low-risk
group defined by CURB-65 (9 patients, 4%).
These findings are also reflected by ROC analysis, as
shown in Table 3 and Figures 1 and 2. In terms of risk
categories, CURSI performed worse (AUROC value: 0.62)
than the CURB-65 (0.67), whereas for score points,
Table 1 Characteristics of the study cohort (N = 553)
n %
a. Demographics
Age≥ 65 years 430 77.8
Sex (female) 246 44.5
b. Comorbidity
Nursing home residency 145 26.2
Immobility 145 26.2
Congestive heart failure 121 21.9
Cerebrovascular disease 114 20.6
Dementia 170 30.7
Chronic lung disease 159 28.8
Diabetes mellitus 157 28.4
Chronic kidney disease 147 26.6
Neoplastic disease 35 6.3
c. Severity criteria
Confusion 94 17.0
Urea >7 mmol/L 287 51.9
Respiratory rate ≥30/min 46 8.3
Blood pressure <90/≤60 mm Hg 133 24.1
Shock index >1.0 70 12.7
d. Outcome
ICU* treatment during hospital stay 58 10.5
30-day mortality 59 10.7
*ICU: intensive care unit.
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AUROC values of CURSI and CURB-65 proved to be
comparable. The AUROC of the CRB-65 was lowest
in both cases.
When patients were dichotomised into a low-risk and
a non-low-risk group, sensitivity, specificity and cor-
responding 95% CI were as follows: for CRB-65 95%
[86%–99%] and 17% [14%–21%], for CURB-65 85%
[73%–93%] and 41% [37%–45%] and for CURSI 42%
[30%–56%] and 81% [77%–85%], respectively. Hence,
the CURSI had the lowest sensitivity with a resulting
higher mortality in the low-risk group. Using the alter-
native cut-off (0 points), values for the CURSI-defined
risk groups would change to 86% [75%–94%] and 38%
[34%–42%]. This is similar to the characteristics of
CURB-65, as mentioned above.
The following positive likelihood ratios were found: for
CRB-65 1.14 [1.07-1.23], for CURB-65 1.43 [1.26-1.63],
and for CURSI 2.25 [1.59-3.19]. The corresponding
negative likelihood ratios for CRB-65, CURB-65 and
CURSI were: 0.30 [0.10-0.92], 0.37 [0.20-0.69], and 0.71
[0.57-0.89].
Discussion
The aim of our study was to assess the performance of
the CAP severity score CURSI [16] in predicting short-
term mortality and to compare it to the established
scores CRB-65 and CURB-65. Our findings show that
increasing score points and risk categories of CURSI
are associated with increasing 30-day mortality in CAP
Table 2 30-day mortality stratified by score points and
risk categories
Severity score Score points No. of patients Mortality
N = 553 n %
CRB-651 0 87 3 3.4
1 271 24 8.9
2 155 24 15.5
3 38 8 21.1
4 2 0 0
CURB-652 0 73 2 2.7
1 138 7 5.1
2 200 23 11.5
3 116 19 16.4
4 26 8 30.8
5 0 0 0
CURSI3 0 195 8 4.1
1 240 26 10.8
2 98 16 16.3
3 19 8 42.1
4 1 1 100
Severity score Risk category No. of patients Mortality
N = 553 n %
CRB-654 Low risk 87 3 3.4
Intermediate risk 426 48 11.3
High risk 40 8 20.0
CURB-655 Low risk 211 9 4.3
Intermediate risk 200 23 11.5
High risk 142 27 19.0
CURSI6 Low risk 435 34 7.8
High risk 118 25 21.2
Definition of risk categories.
CRB-65: low risk = 0 points; intermediate risk = 1–2 points; high risk = 3–4 points.
CURB-65: low risk = 0–1 points; intermediate risk = 2 points; high risk = 3–5 points.
CURSI: low risk = 0–1 points; high risk = 2–4 points.
P-values according to chi-square test: 1p = 0.007; 2p < 0.001; 3p < 0.001; 4p = 0.014;
5p < 0.001; 6p < 0.001.
Table 3 Area under the receiver operating characteristic
curve (AUROC) for CRB-65, CURB-65 and CURSI









Definition of risk categories.
CRB-65: low risk = 0 points; intermediate risk = 1–2 points; high risk = 3–4 points.
CURB-65: low risk = 0–1 points; intermediate risk = 2 points; high risk = 3–5 points.
CURSI: low risk = 0–1 points; high risk = 2–4 points.
Figure 1 Receiver operating characteristic (ROC) curves for
score points.
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patients. However, CURSI does not outperform the other
scores, and has some limitations.
One of the most important steps in managing CAP in-
volves deciding whether a patient can safely be regarded
as being at low risk of mortality. This would offer the
perspective to align several management decisions to
risk, with hospital admission being the most important
decision. Admission to hospital multiplies the treatment
costs, harbours the danger of hospital-acquired infections
and is associated with a slower return to work and usual
activities [19-22]. Therefore, our analysis focused on the
ability of the severity scores to identify patients at low
risk of mortality, or in other words on the sensitivity of
the severity scores used. In comparison to CRB-65 and
CURB-65 (sensitivity about 95% and 85%, respectively),
CURSI had a markedly lower sensitivity (around 42%).
The 95% CI showed no overlap between CRB-65 or
CURB-65 and CURSI. In our view, this finding indi-
cates a clinically important difference in sensitivity be-
tween CBR-65 or CURB-65 and CURSI that is unlikely to
be explained by chance alone. The mentioned finding is
also reflected by the negative likelihood ratios found. The
negative likelihood ratios show that being identified as low
risk by CRB-65 or CURB-65 indicates a much lower
chance for mortality at day 30 than being defined as low
risk by CURSI.
Compared to CURB-65, CURSI identifies twice as ma-
ny patients as being at low risk. However, this possible
advantage is nullified by the high mortality in this group.
This limitation could only be avoided by lowering the
proposed cut-off [16]. The resulting values (sensitivity,
specificity, number of patients and mortality in the low-
risk group) would be very similar to those of CURB-65.
However, a modification of the CURSI-defined low-risk
group would require further validation studies. By con-
trast, CRB-65 and CURB-65 have already been well vali-
dated in recent years [9,11-15].
Two further aspects deserve consideration. The risk
categories as proposed for the CURSI do only differenti-
ate between a low risk and a high risk group. By con-
trast, CRB-65 and CURB-65 based categories also define
an intermediate risk group. Current guidelines [23,24]
do not recommend basing the indication for ICU admis-
sion on severity scores, like CRB-65 or CURB-65. How-
ever, the differentiation of patients not being low risk
may allow a further differentiation of treatment inten-
sities, for example intensity of clinical monitoring. Fur-
ther, in our opinion, replacing the criteria age and blood
pressure of CURB-65 by shock index in CURSI offers no
practical advantage. Age can be assessed easily in nearly
all patients. Blood pressure is also part of the shock
index and thus has to be measured in both cases.
The motivation for developing CURSI was the as-
sumed inaccuracy of the criteria age and blood pressure
of CURB-65 with reference to the high prevalence of hy-
pertension in elderly patients and the low correlation be-
tween chronological and biological age [16]. The shock
index was purported to be a better marker for pneumo-
nia severity and had already been shown to correlate
with mortality in CAP patients [17]. We can confirm this
observation with our data. However, we can also confirm
that age is a strong predictor of short-term mortality,
which has already been shown repeatedly [15,25-27]. On
this basis, a simple, yet likely explanation why CURSI is
not able to outperform CRB-65 or CURB-65 would be
that it only substitutes one strong predictor variable (age)
with another (shock index).
The test performance of CURB-65 and CRB-65 found
in our analysis is comparable to other studies. In their
analysis describing and evaluating the CURB-65, Lim
et al. [7] reported a sensitivity of 93% and a specificity of
49% for the identification of the low risk group. The per-
formance of the CRB-65 was worse (77% and 64% sensi-
tivity and specificity, respectively), but still comparable.
Likewise, several other studies found sensitivity and spe-
cificity for CURB-65 to be between 80%-90% and 50%-
60%, respectively [9,13,28]. In the original CURSI study
[16], Myint et al. reported only 60% and 75% for sensi-
tivity and specificity for the CURB-65. For CURSI, the
figures were 61% and 72%, which is somewhat better
than the estimates we derived from our analysis. How-
ever, as it seems, the equivalent results of Myint et al.
for CURSI and CURB-65 are caused by the relatively
weak performance of the CURB-65 rather than a good
performance of the CURSI.
The AUROC of the CRB-65 was lower compared to
the other severity scores. This can be explained by the
Figure 2 Receiver operating characteristic (ROC) curves for
risk categories.
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omission of the urea criterion, which has been shown to
be significantly associated with mortality in CAP patients
[7,29-31]. Furthermore, CRB-65 identified fewer patients
at low risk than CURB-65 (87 vs. 211), but showed better
sensitivity with a resulting even slightly lower mortality in
the low-risk group. These findings are consistent with sev-
eral other studies [7,9,12,28,32]. CRB-65 is recommended
for use in ambulatory care [6,23,24], as CURB-65 requires
the blood urea value, which may not be available in all
cases or might delay decision-making. In a large prospect-
ive German study including inpatients and outpatients
with CAP [33], blood urea was available for fewer than
half of the outpatients included in the study.
Our study has limitations. One limitation is the retro-
spective design and the use of registry data for analysis.
However, we do not believe that this affects the validity
of our findings. The registry was established for the pur-
pose of quality assurance and contains reliable and com-
plete information on all variables of the CRB-65. Data are
entered into the database in time, i.e. during hospital stay
of the patient or immediately after discharge. The corre-
sponding blood urea values could be retrieved from the
central laboratory server without any missings. Pulse rate
was clearly documented on admission in all but six cases
(1.1% of all cases). Reliable information on 30-day mortal-
ity as the primary endpoint was provided for all patients
by the relevant local register office. With this, we are con-
vinced that the data for the variables of interest, namely
the three severity scores used and mortality as the primary
endpoint, are valid. Another limitation is that only in-
patients were included. Therefore, no statement can be
made as to whether patients identified as being at low
risk can be safely treated as outpatients. This hypothesis
demands testing in prospective, randomised controlled
trials. Finally, we present data from a single centre only.
In terms of CRB-65 and CURB-65 performance, our re-
sults are in line with several other studies. However, as
characteristics of hospitals and populations served can
differ widely, generalisability of our findings is certainly
limited.
Conclusions
The risk categorisation based on the new CAP severity
score CURSI was not suitable for predicting low risk of
death in our analysis. By lowering the cut-off for the
low-risk group, CURSI could match CURB-65 in terms
of identifying low-risk patients. However, using CURSI
instead of CURB-65 provides no practical advantage, and
CURB-65 is much better validated and already imple-
mented in current guidelines.
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